Historic antitrust case against Momenta Pharmaceuticals over illegal drug price-fixing led to second largest indirect purchaser antitrust pharmaceutical settlement in history The American Antitrust Institute has announced its selection of leading practitioners and economists to be recognized as honorees for the 2020 Antitrust Enforcement Awards. Lieff Cabraser’s team shared the AAI’s
Lawsuit alleged the companies agreed to under-the-table and illegal deals to not-hire each other’s employees in order to keep wages and job competition low On August 26, 2020, Judge Joy Flowers Conti of the U.S. District Court for the Western District of Pennsylvania granted final approval to a settlement of the labor antitrust litigation filed
This case on behalf of non-medical faculty follows Lieff Cabraser Heimann & Bernstein LLP’s successful similar action against Duke on behalf of medical faculty that led to a $54.5 million settlement in 2019. May 27, 2020, Durham, North Carolina—(BUSINESSWIRE)—Lieff Cabraser, Edelstein & Payne, and Elliot Morgan Parsonage announce the filing of a class action labor
As reported by Law360 (subscription), a New York federal judge has granted class certification in an antitrust lawsuit wherein Lieff Cabraser and co-counsel represent a group of pharmaceutical purchasers, union benefit plans, and other buyers of Allergan’s blockbuster dry-eye disease drug Restasis. The sweeping litigation accuses the drugmaker of misconduct intended
The American Bar Association Section of Antitrust Law recently submitted comments to the Federal Trade Commission in connection with the January 2020 FTC workshop on “Non-Competes in the Workplace: Examining Antitrust and Consumer Protection Issues.” In section two of the submission, Lieff Cabraser partner Dean M. Harvey provided detailed commentary on the “Impact of Non-compete
First-of-its-kind class action antitrust case brought by Lieff Cabraser and Justice Catalyst Law, Public Counsel, the National Consumer Law Center, and Towards Justice alleging that insurance companies in California conspired to unlawfully inflate California bail bond premiums will move forward to discovery and trial On April 13, 2020, Judge Jon S. Tigar of the U.S.
As reported by Law360 (Subscription), U.S District Judge Joy Flowers Conti has indicated she is close to granting preliminary approval to a $48.95 million settlement of the antitrust lawsuit in which employee plaintiffs alleged Knorr-Bermse AG and Wabtec Corp. improperly agreed not to hire each other’s employees resulting in suppressed and lost wages. The settlement
Proposed settlements with world’s dominant railway equipment suppliers will provide $48.95 million for employees who alleged their compensation was adversely impacted by an agreement between Knorr and Wabtec not to poach each other’s employees Lieff Cabraser Heimann & Bernstein, LLP and Fine, Kaplan and Black, R.P.C. announce a total of $48.95 million in settlements to
Kellum is Fourth Executive to Be Charged in Ongoing Investigation A former senior executive pleaded guilty today for his role in a conspiracy to fix prices, rig bids, and allocate customers for generic drugs, the Department of Justice has announced. According to court documents, from at least March 2013 until at least June 2015, Hector Armando
Lieff Cabraser serves as counsel for amicus AAI, who successfully secured denial of drug makers’ requested injunction against the new pro-competition law AB 824 Lieff Cabraser serves as counsel for amicus American Antitrust Institute, on whose behalf the firm filed a brief in opposition to drug makers’ attempts to enjoin a new California law (AB